Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A complete guide to metformin's FDA approval history, compounding legal status, label requirements, and post-market safety record. Reviewed by the HealthRX medical team.
Read clinical reviewA side-by-side comparison of how the FDA and EMA regulate metformin, including approval history, label differences, renal thresholds, safety monitoring, and post-market surveillance.
Read clinical reviewA clinical review of metformin safety signals in the FDA Adverse Event Reporting System (FAERS), including lactic acidosis, B12 deficiency, NDMA contamination, and updated renal dosing guidance.
Read clinical reviewA complete timeline of metformin's FDA approval, label expansions, safety reviews, and regulatory milestones from 1994 to the present day.
Read clinical reviewA complete overview of metformin's regulatory history across the FDA, EMA, and other global agencies, including approval timelines, labeling updates, NDMA concerns, and current prescribing status.
Read clinical reviewA complete timeline of metformin FDA label changes from 2020 through 2026, including the eGFR renal threshold expansion, NDMA impurity recalls, vitamin B12 monitoring, and updated lactic acidosis language.
Read clinical reviewA complete guide to metformin's regulatory history, patent expiration, FDA label updates, NDMA contamination actions, and ongoing post-market safety surveillance, reviewed by the HealthRX medical team.
Read clinical reviewA comprehensive look at metformin's FDA approval history, current label requirements, post-market surveillance findings, and what next-generation biguanide-class research means for clinical practice.
Read clinical review